Early Pharmacological Treatment of Autism: A Rationale for Developmental Treatment

This publication has 264 references indexed in Scilit:

• Gender-Dependent Modulation of Brain Monoamines and Anxiety-like Behaviors in Mice with Genetic Serotonin Transporter and BDNF Deficiencies
  Cellular and Molecular Neurobiology, 2006
• Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
  Neuropharmacology, 2005
• Placebo effects in developmental disabilities: Implications for research and practice
  Mental Retardation and Developmental Disabilities Research Reviews, 2005
• Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome
  Neuron, 2005
• ‘Nurturing the brain’ as an emerging research field involving child neurology
  Brain & Development, 2004
• Serum neurotrophin concentrations in autism and mental retardation: a pilot study
  Brain & Development, 2004
• The mGluR theory of fragile X mental retardation
  Published by Elsevier ,2004
• Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid‐compulsive subset of autism
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2003
• Genetic studies in autistic disorder and chromosome 15
  neurogenetics, 2000
• Autism
  Pediatric Drugs, 2000